Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Br J Radiol ; 83(986): 129-32, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19546178

RESUMEN

To increase the survival rate of patients with acute superior mesenteric artery thromboembolism (ASMAT) treated by catheter thrombolysis, we examined the effects of delivering edaravone and asialoerythropoietin, agents with tissue-protective activities, using a rabbit autologous fibrin clot ASMAT model. Japanese white rabbits (n=32) were randomly separated into four equal groups. 45 min after introducing autologous fibrin clot, Group U received urokinase and heparin; Group E received urokinase and heparin plus edaravone; Group A received urokinase and heparin plus asialoerythropoietin; and Group EA received urokinase, heparin and edaravone plus asialoerythropoietin via a catheter. The intestines were removed 6 h later and intestinal mucosal damage was scored using the Park's injury score. Survival time was assessed. Average mucosal injury was 5.78+/-1.52 (Group U), 2.88+/-0.72 (Group E), 1.90+/-1.23 (Group A) and 1.18+/-1.25 (Group EA). The degree of mucosal injury was significantly lower in Group EA than in Groups U and E (p<0.05). Conversely, there was no significant difference between Group A and Group EA, or between Group A and Group E. The survival times were 31.50+/-13.30 h (Group U), 51.00+/-24.74 h (Group E), 48.00+/-16.97 h (Group A) and 82+/-51.07 h (Group EA); the difference among the four groups was not significant. In conclusion, the concomitant administration of asialoerythropoietin and edaravone reduced mucosal membrane injury significantly compared with edaravone alone. However, to improve the survival of ASMAT rabbit models, the delivery of an appropriate dose of asialoerythropoietin is required, together with the development of methods to assess peripheral recanalisation.


Asunto(s)
Antipirina/análogos & derivados , Asialoglicoproteínas/administración & dosificación , Eritropoyetina/análogos & derivados , Depuradores de Radicales Libres/administración & dosificación , Oclusión Vascular Mesentérica/complicaciones , Daño por Reperfusión/prevención & control , Tromboembolia/complicaciones , Animales , Antipirina/administración & dosificación , Antipirina/farmacología , Asialoglicoproteínas/farmacología , Cateterismo , Modelos Animales de Enfermedad , Combinación de Medicamentos , Edaravona , Eritropoyetina/administración & dosificación , Eritropoyetina/farmacología , Fibrina , Fibrinolíticos/uso terapéutico , Depuradores de Radicales Libres/farmacología , Heparina/uso terapéutico , Inyecciones Intraarteriales , Mucosa Intestinal/patología , Arteria Mesentérica Superior , Oclusión Vascular Mesentérica/tratamiento farmacológico , Oclusión Vascular Mesentérica/mortalidad , Conejos , Distribución Aleatoria , Daño por Reperfusión/etiología , Daño por Reperfusión/patología , Tasa de Supervivencia , Tromboembolia/tratamiento farmacológico , Tromboembolia/mortalidad , Activador de Plasminógeno de Tipo Uroquinasa/uso terapéutico
5.
Lupus ; 16(5): 363-5, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17576740

RESUMEN

Panniculitis rarely occurs in the course of systemic lupus erythematosus (SLE). When it occurs, it is thought to be mainly lupus erythematosus panniculitis (LEP). Here we describe a 32-year old Japanese woman with chronic SLE, who simultaneously presented facial lymphocytic lobular panniculitis and pancytopenia due to haemophagocytic syndrome. She showed several auto-antibodies against trilineage haematopoetic cells, an anti-cardiolipin antibody, and no evidence of viral infection, indicating that her haemophagocytic syndrome might be autoimmune-associated haemophagocytic syndrome. The panniculitis and haemophagocytic syndrome presented simultaneously, and these manifestations were dramatically improved with corticosteroid therapy; therefore, the lymphocytic lobular panniculitis could be linked to autoimmune-associated haemophagocytic syndrome in this case.


Asunto(s)
Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/patología , Paniculitis de Lupus Eritematoso/complicaciones , Paniculitis de Lupus Eritematoso/patología , Adulto , Biopsia , Enfermedad Crónica , Urgencias Médicas , Femenino , Humanos , Lupus Eritematoso Sistémico/cirugía , Paniculitis de Lupus Eritematoso/cirugía
6.
Diabetologia ; 50(4): 867-73, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17225121

RESUMEN

AIMS/HYPOTHESIS: The early identification of type 2 diabetic patients at risk of developing microalbuminuria-an independent risk factor for renal and cardiovascular diseases-is important to improve the patients' outcomes. We investigated whether serum levels of IL-18, a proinflammatory cytokine, were a predictor of early renal dysfunction. MATERIALS AND METHODS: A total of 249 Japanese type 2 diabetic patients without overt proteinuria were enrolled in an observational follow-up study (median follow-up 7 years), and their stage of diabetic nephropathy was classified and their estimated glomerular filtration rate (eGFR) was calculated annually. RESULTS: At baseline, serum levels of IL-18 were higher in subjects with microalbuminuria (n = 76) than in those with normoalbuminuria (n = 173). Elevated serum levels of IL-18 were associated with the progression of nephropathy to a higher stage in normoalbuminuric subjects (118 [interquartile range 91-159] ng/l vs 155 [interquartile range 121-205] ng/l, p = 0.003), but not in microalbuminuric subjects (154 [interquartile range 113-200] ng/l vs 160 [interquartile range 101-190] ng/l, p = 0.50). The adjusted risk for developing microalbuminuria was 3.6 (95% CI 1.2-10.4) in normoalbuminuric subjects with serum IL-18 levels above the median (>/=134.6 ng/l), and was significantly enhanced in those urinary AERs at the upper end of the normal range (7.5 mug/min

Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Nefropatías Diabéticas/sangre , Nefropatías Diabéticas/diagnóstico , Interleucina-18/sangre , Enfermedades Renales/sangre , Enfermedades Renales/complicaciones , Anciano , Proteína C-Reactiva/metabolismo , Complicaciones de la Diabetes/diagnóstico , Complicaciones de la Diabetes/metabolismo , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Inflamación , Interleucina-18/metabolismo , Japón , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad , Resultado del Tratamiento
7.
Nephron Clin Pract ; 105(2): c54-7, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17135768

RESUMEN

BACKGROUND/AIMS: In patients with primary renal diseases the current knowledge of hyperglycemia associated with corticosteroid therapy is limited. We therefore examined the prevalence and risk factors of glucocorticoid-induced diabetes mellitus (DM) in primary renal diseases. METHODS: Patients were recruited with primary renal diseases who were started on corticosteroids between April 2002 and June 2005. In patients with DM, an impaired fasting glucose level and/or positive urinary glucose analyses before corticosteroids therapy were excluded. RESULTS: During corticosteroid therapy (initial dose: prednisolone 0.75 +/- 0.10 mg/kg/day), DM was newly diagnosed in 17 (40.5%) of 42 patients. All of the 17 patients were diagnosed as having DM by postprandial hyperglycemia at 2 h after lunch, although they had normal fasting blood glucose levels. Age (OR 1.40, 95% CI 1.06-1.84) and body mass index (OR 1.87, 95% CI 1.03-3.38) were determined as independent risk factors for glucocorticoid-induced DM. CONCLUSION: Over 40% of patients with primary renal disease developed DM during treatment with corticosteroids. A high age and high body mass index are the independent risk factors for glucocorticoid-induced DM. 24-hour urinary glucose analyses and postprandial plasma glucose are useful for detecting glucocorticoid-induced DM.


Asunto(s)
Diabetes Mellitus/inducido químicamente , Diabetes Mellitus/epidemiología , Glucocorticoides/efectos adversos , Enfermedades Renales/tratamiento farmacológico , Adulto , Factores de Edad , Glucemia/análisis , Índice de Masa Corporal , Ritmo Circadiano , Diabetes Mellitus/diagnóstico , Femenino , Glucocorticoides/uso terapéutico , Glucosuria/fisiopatología , Humanos , Hiperglucemia/inducido químicamente , Masculino , Metilprednisolona/efectos adversos , Persona de Mediana Edad , Periodo Posprandial , Prednisolona/efectos adversos , Prevalencia , Factores de Riesgo
11.
J Hum Hypertens ; 15(5): 323-7, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11378834

RESUMEN

Recently we found that, in non-dipper type of essential hypertensive patients who showed the lack of nocturnal fall in blood pressure, circadian rhythm of urinary sodium excretion rate was disturbed. In the present study we examined whether postural change in natriuresis is also disturbed in non-dippers. Sixteen inpatients with essential hypertension were maintained on a relatively high sodium diet containing 10 to 12 g of NaCl per day for 8 days. On the 7th day of the study period, 24-h ambulatory blood pressures were measured, and 5-7th days urinary samples were collected for both daytime and night-time. On the last day of the study period, patients stood for 2 h and then lay down for 2 h. Urinary volume and excretion rates of creatinine and sodium were measured every hour in both positions. Night-time urinary sodium excretion rate was significantly higher in non-dippers (n = 9) than that in dippers (n = 7). Night/day ratio of mean arterial pressure had a positive relationship with night/day ratio of urinary sodium excretion rate. In non-dippers, but not in dippers, the mean value of U(Na)V during upright position was significantly lower than that during supine position. There was a significantly negative relationship between upright/supine ratio of U(Na)V and night/day ratio of MAP or night/day ratio of U(Na)V. In patients with non-dipper type of essential hypertension, both natriuresis patterns, circadian rhythm and postural change, were disturbed.


Asunto(s)
Ritmo Circadiano , Hipertensión/fisiopatología , Natriuresis/fisiología , Postura , Sodio/metabolismo , Adulto , Anciano , Determinación de la Presión Sanguínea/métodos , Femenino , Frecuencia Cardíaca/fisiología , Hemodinámica/fisiología , Humanos , Hipertensión/diagnóstico , Pruebas de Función Renal , Masculino , Persona de Mediana Edad , Probabilidad , Sensibilidad y Especificidad , Sodio/administración & dosificación , Posición Supina
13.
Am J Kidney Dis ; 36(3): 592-9, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10977792

RESUMEN

Hemodialysis (HD) patients have a high rate of cardiac morbidity and mortality. Both symptomatic and silent ischemic heart disease may occur frequently during HD because HD simultaneously reduces coronary artery oxygen delivery while increasing myocardial oxygen demand. The purpose of the present study is to prospectively evaluate the usefulness of a significant ST depression induced by HD for the diagnosis of coronary artery disease (CAD) and as the predictor of subsequent cardiac events in HD patients. Sixty-one patients undergoing chronic HD (50 men, 11 women; mean age, 61 years) admitted for such cardiac symptoms as chest pain (n = 43), arrhythmia (n = 5), or heart failure (n = 13) were studied; 38 patients had CAD by coronary angiography. Electrocardiograms performed during HD showed an additional depression (>/=1.0 mV) of the ST segment in 18 patients (positive-ST group), but not in 43 patients (negative-ST group). The incidence of CAD was significantly greater in the former (100%) than in the latter group (46%). A prospective follow-up was performed for 21 +/- 2 months, and cardiac events occurred in all positive-ST group patients and in 21 negative-ST group patients. Event-free survival was poorer in the positive-ST group (P < 0.0001). A Cox proportional hazards model identified the significant ST depression as an independent risk factor for cardiac morbidity (P < 0.05), but not for all-cause mortality. ST depression during HD is useful to diagnose CAD in symptomatic patients and is considered an important prognosticator of subsequent cardiac events.


Asunto(s)
Enfermedad Coronaria/diagnóstico , Electrocardiografía , Diálisis Renal/efectos adversos , Análisis de Varianza , Angina de Pecho/etiología , Enfermedad Coronaria/mortalidad , Enfermedad Coronaria/fisiopatología , Muerte Súbita Cardíaca/etiología , Complicaciones de la Diabetes , Supervivencia sin Enfermedad , Femenino , Pruebas de Función Cardíaca , Humanos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/fisiopatología , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/etiología , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Factores Sexuales
14.
Cancer Lett ; 157(2): 193-200, 2000 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-10936680

RESUMEN

We have developed a simple system for rapid detection and measurement of glutathione S-transferase placental form (GSTP1) that detoxify polycyclic aromatic hydrocarbons using the cultured rat normal liver epithelial cell line, (RL34) cells. Survey of fruit extracts for GST inducing ability identified both papaya and avocado as significant sources. Benzyl isothiocyanate (BITC) was isolated from papaya methanol extract as a principal inducer of GST activity. Further, the GST inducing ability of a total of 20 isothiocyanates (ITCs) and their derivatives was investigated. Some ITCs showed significant induction, and BITC was one of the most potent inducers among all compounds tested in the present study. The modification of isothiocyanate group (-NCS) or introduction of substituent group to the alpha-carbon modifies GST induction. Moreover, a significant correlation (P<0.01, r=0.913) between the GST activity enrichment and GSTP1 protein induction by ITCs was observed. We also indicated that phenethyl ITC and nitrophenyl ITC, potently inducing GST activity, but not inactive benzyl isocyanate, are potential inducers of intracellular reactive oxygen intermediates (ROIs). Our system of GSTP1 induction is appropriate for the chemical research such as screening and identification of novel type of inducers as well as the structure-activity relationship studies, providing mechanistic insight into essential structural elements for GSTP1 induction.


Asunto(s)
Frutas , Glutatión Transferasa/biosíntesis , Isotiocianatos/metabolismo , Hígado/metabolismo , Animales , Western Blotting , Células Cultivadas , Inducción Enzimática , Células Epiteliales/metabolismo , Fluorescencia , Isotiocianatos/química , Lauraceae , Hígado/citología , Ratas , Especies Reactivas de Oxígeno , Relación Estructura-Actividad
15.
Stroke ; 31(1): 61-5, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10625716

RESUMEN

BACKGROUND AND PURPOSE: Atherosclerotic renal artery stenosis commonly exists as one manifestation of more generalized atherosclerosis. It is a progressive but potentially curable disorder. Thus, information on renal artery involvement in atherosclerotic diseases could be important. We investigated the prevalence of renal artery stenosis in autopsied patients with stroke over 40 years of age. METHODS: From 2167 consecutive autopsy patients who died between 1980 and 1997, we studied 346 cases of mean age of 69+/-11 years with clinical evidence of stroke. RESULTS: Atherosclerotic renal artery stenosis (>/=75% luminal area narrowing) was found in 36 patients (10.4%). Patients with renal artery stenosis were older and had worse renal function. Renal artery stenosis was found in 14.7%, 28.6%, and 23.9% of patients with hypertension, renal insufficiency, and aortic aneurysm, respectively. Extracranial carotid artery stenosis (>50% luminal area narrowing) was found in 101 patients (29.2%). Of the 346 stroke patients, 256 had a history of brain infarction. In patients with brain infarction, renal artery stenosis was found in 31 (12.1%) and carotid stenosis was found in 81 (33.6%). Patients with carotid artery stenosis were more likely to have renal artery stenosis than patients without carotid artery stenosis (24.4% versus 5.9%, P<0.0001). Multiple logistic regression analysis identified renal insufficiency, hypertension, female gender, and presence of carotid artery stenosis as independent predictors of renal artery stenosis in patients with brain infarction. CONCLUSIONS: These data reveal that atherosclerotic renal artery stenosis is common in patients with stroke, especially in those with brain infarction.


Asunto(s)
Obstrucción de la Arteria Renal/complicaciones , Accidente Cerebrovascular/complicaciones , Anciano , Anciano de 80 o más Años , Autopsia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Obstrucción de la Arteria Renal/patología , Accidente Cerebrovascular/patología
16.
Circulation ; 100(15): 1635-8, 1999 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-10517735

RESUMEN

BACKGROUND: Recently, we found that sodium restriction shifted the circadian rhythm of blood pressure from nondipper to dipper in patients with the sodium-sensitive essential hypertension. This study examined whether diuretics can transform the circadian rhythm of blood pressure from nondipper to dipper. METHODS AND RESULTS: We studied 21 patients with essential hypertension during both a baseline period and a period of treatment with hydrochlorothiazide (25 mg daily). The periods lasted 4 weeks each. Twenty-four hour ambulatory blood pressures were measured on the same day of the week at the end of the each period. In nondippers (n=11), but not in dippers (n=10), a significant interaction existed between diuretic therapy and nocturnal fall in systolic and diastolic blood pressure, which indicated that the degree of nocturnal blood pressure fall was affected by diuretic therapy. Nocturnal fall, which was diminished in nondippers, was restored by diuretic therapy with hydrochlorothiazide, indicating that the circadian rhythm of blood pressure shifted from nondipper to dipper patterns. CONCLUSIONS: The present study demonstrated that diuretics can restore nocturnal blood pressure decline in a manner similar to sodium restriction, which suggests that the kidneys and sodium metabolism may play important roles in the genesis of the circadian rhythm of blood pressure. Diuretic-based treatment may have an additional therapeutic advantage of reducing the risk for cardiovascular complications by transforming the circadian rhythm of blood pressure.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Ritmo Circadiano/efectos de los fármacos , Hidroclorotiazida/farmacología , Hipertensión/fisiopatología , Natriuresis/efectos de los fármacos , Inhibidores de los Simportadores del Cloruro de Sodio/farmacología , Anciano , Antihipertensivos/farmacología , Antihipertensivos/uso terapéutico , Presión Sanguínea/fisiología , Diuréticos , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Hidroclorotiazida/uso terapéutico , Hipertensión/clasificación , Hipertensión/tratamiento farmacológico , Riñón/efectos de los fármacos , Riñón/fisiopatología , Masculino , Persona de Mediana Edad , Sodio/metabolismo , Inhibidores de los Simportadores del Cloruro de Sodio/uso terapéutico
18.
J Hum Hypertens ; 13(4): 257-62, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10333344

RESUMEN

We recently showed that cardiovascular morbidity was higher in sodium sensitive type of essential hypertension than in the non-sodium sensitive type. It was examined whether sodium sensitivity was associated with insulin resistance, an important atherosclerotic cardiovascular risk factor in essential hypertension. Fifty-three patients with essential hypertension, who had normal (n = 12) and impaired (n = 41) glucose tolerance, were placed on high (12-15 g NaCl/day) and low (1-3 g) sodium diets for 1 week each to determine sodium sensitivity. Fasting plasma glucose and insulin concentrations were measured on a regular sodium diet. The homeostasis model assessment insulin resistance index (fasting glucose [mmol/L] x fasting insulin [mU/L]/22.5) was 1.40+/-0.10 and 1.47+/-0.14 in non-sodium sensitive and sodium sensitive groups. The insulin resistance index was positively correlated with the sodium sensitivity index, while was negatively correlated with fractional excretion of sodium (FE(Na)) obtained during a high sodium diet. In addition, the insulin resistance index had a positive relationship with overall creatinine clearance. Sodium sensitivity index was also negatively correlated with FE(Na) obtained during a high sodium diet. These results showed that insulin resistance might participate in the genesis of sodium sensitivity in essential hypertension by enhancing tubular sodium reabsorption, as reflected in decreased FE(Na) and augmented creatinine clearance. Insulin resistance seemed elevated in sodium sensitive state of essential hypertension, leading to future cardiovascular events.


Asunto(s)
Hipertensión/etiología , Resistencia a la Insulina , Sodio/metabolismo , Absorción , Adulto , Anciano , Glucemia/metabolismo , Presión Sanguínea , Creatinina/metabolismo , Femenino , Humanos , Hipertensión/sangre , Hipertensión/orina , Insulina/sangre , Túbulos Renales/metabolismo , Masculino , Persona de Mediana Edad , Factores de Riesgo , Sodio en la Dieta/administración & dosificación
19.
Am J Hypertens ; 12(1 Pt 1): 35-9, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10075382

RESUMEN

It has been postulated that the lack of nocturnal blood pressure fall in patients called nondippers is associated with more serious end organ damages by hypertension than in dippers whose blood pressure falls during the night. Recently, we found that sodium restriction shifted circadian rhythm of blood pressure from that of a nondipper to a dipper in patients with essential hypertension. In the present study, we aimed to clarify these important findings from the different approaches, and examined which factors affected the diurnal rhythm of blood pressure. A total of 70 patients with essential hypertension were maintained on high and low sodium diets for 1 week each. Nocturnal fall in mean arterial pressure was calculated in each patient, and, based on multiple regression analysis, independent factors affecting this nocturnal fall were examined. Thirty-eight patients were classified as non-sodium-sensitive, whereas 32 were considered sodium sensitive, based on a >10% change in 24-h mean arterial pressure by sodium restriction. In all 70 patients, sodium sensitivity of blood pressure, as well as an interaction between sodium sensitivity and sodium restriction, were identified as independent factors affecting the nocturnal fall. In sodium-sensitive types, in addition to sodium restriction, glomerular filtration rate was identified, whereas, in non-sodium sensitive types, there was no significant factor. Based on multiple regression analysis, the present study reached the same important conclusion as our previous findings: namely, that the enhanced sodium sensitivity was an independent determinant for the diminished nocturnal fall in essential hypertension and that sodium restriction could restore the nocturnal decline, especially in patients with enhanced sodium sensitivity whose nocturnal decline was diminished. Reduced renal sodium excretory capability may be one of the mechanisms involved in nondipping.


Asunto(s)
Presión Sanguínea/fisiología , Ritmo Circadiano , Hipertensión/fisiopatología , Adulto , Anciano , Monitoreo Ambulatorio de la Presión Arterial , Creatinina/orina , Dieta Hiposódica , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular , Humanos , Hipertensión/dietoterapia , Hipertensión/orina , Masculino , Persona de Mediana Edad , Natriuresis/fisiología , Sodio/orina , Sodio en la Dieta/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA